Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | MAOB | P27338 | 5/20 | 0.45 |
| ▸ | ESR1 | P03372 | 1/20 | 0.45 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.45 |
| ▸ | MMP12 | P39900 | 1/20 | 0.44 |
| ▸ | MMP13 | P45452 | 1/20 | 0.44 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
| ▸ | TYR | P14679 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL168135 | 0.89 | HSD17B10 (0.59) | KMT2AHSD17B10ALDH1A1L3MBTL1LMNA | |
| SCHEMBL9251076 | 0.87 | HSD17B10 (0.57) | KMT2AHSD17B10ALDH1A1L3MBTL1LMNA | |
| SCHEMBL11612809 | 0.84 | KMT2A (0.59) | KMT2AHSD17B10ALDH1A1L3MBTL1LMNA | |
| SCHEMBL2387794 | 0.82 | NPC1 (0.57) | KMT2AALDH1A1RAB9AMAPTNPC1 | |
| SCHEMBL86139 | 0.82 | ALDH1A1 (0.47) | HSD17B10ALDH1A1L3MBTL1RAB9AMAPT | |
| SCHEMBL4242570 | 0.82 | ALDH1A1 (0.62) | KMT2AALDH1A1RAB9AMAPTNPC1 | |
| SCHEMBL8652676 | 0.82 | LMNA (0.45) | ALDH1A1L3MBTL1LMNARAB9AMAPT | |
| SCHEMBL3975016 | 0.82 | NPC1 (0.43) | KMT2AHSD17B10ALDH1A1L3MBTL1LMNA | |
| SCHEMBL7365104 | 0.82 | ESR1 (0.56) | KMT2AALDH1A1LMNARAB9AMAPT | |
| SCHEMBL168852 | 0.82 | GSK3B (0.50) | ALDH1A1L3MBTL1RAB9AMAPTNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3181545-B1 | PROCESS FOR THE PREPARATION OF OSPEMIFENE | SHIONOGI & CO (JP) | 2023-11-01 | — | — | EP | disclosed |
| US-11518733-B2 | Process for preparation of highly pure Fingolimod hydrochloride | SHIVALIK RASAYAN LIMITED (IN) | 2022-12-06 | — | — | US | disclosed |
| CN-110078594-B | Synthetic method of p-hydroxyphenylethanol | 新昌县泰如科技有限公司 | 2022-07-15 | — | — | CN | disclosed |
| US-20170297999-A1 | METHOD FOR PRODUCING TRIPHENYLBUTENE DERIVATIVE | Shionogo & Co., Ltd (JP) | 2017-10-19 | — | — | US | disclosed |
| US-20170297999-A1 | METHOD FOR PRODUCING TRIPHENYLBUTENE DERIVATIVE | Shionogo & Co., Ltd (JP) | 2017-10-19 | — | — | US | disclosed |
| EP-2807143-B1 | PROCESS FOR PREPARATION OF FINGOLIMOD | GLENMARK GENERICS LTD (IN) | 2017-08-30 | — | — | EP | disclosed |
| CN-107074722-A | Method for producing triphenylbutene derivative | 盐野义制药株式会社 | 2017-08-18 | — | — | CN | disclosed |
| EP-3181545-A1 | METHOD FOR PRODUCING TRIPHENYLBUTENE DERIVATIVE | Shionogi & Co., Ltd. (JP) | 2017-06-21 | — | — | EP | disclosed |
| US-8735627-B2 | Intermediate compounds and process for the preparation of fingolimod | MAPI PHARMA LTD. (IL) | 2014-05-27 | — | — | US | disclosed |
| US-20130217899-A1 | INTERMEDIATE COMPOUNDS AND PROCESS FOR THE PREPARATION OF FINGOLIMOD | MAPI PHARMA LTD. (IL) | 2013-08-22 | — | — | US | disclosed |
| US-20090176744-A1 | Deuterated fingolimod | CONCERT PHARMACEUTICALS, INC. (US) | 2009-07-09 | — | — | US | disclosed |
| US-20070112037-A1 | Pyrazole Derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2007-05-17 | — | — | US | disclosed |
| US-20070112037-A1 | Pyrazole Derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2007-05-17 | — | — | US | disclosed |
| US-7183306-B2 | Pyrazole derivatives | ASTELLAS PHARMA INC. (JP) | 2007-02-27 | — | — | US | disclosed |
| US-7183306-B2 | Pyrazole derivatives | ASTELLAS PHARMA INC. (JP) | 2007-02-27 | — | — | US | disclosed |
| US-5385693-A | Having rapid response and low phase transition temperature | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1995-01-31 | — | — | US | disclosed |
| EP-0357372-B1 | Optically active ester derivatives, preparation process thereof, liquid crystal materials and a light switching element | SUMITOMO CHEMICAL CO (JP) | 1994-11-17 | — | — | EP | disclosed |
| US-5264151-A | Optically active ester derivatives, preparation process thereof, liquid crystal materials and a light switching element | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1993-11-23 | — | — | US | disclosed |
| US-5124070-A | High speed response | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1992-06-23 | — | — | US | disclosed |
| EP-0357372-A2 | Optically active ester derivatives, preparation process thereof, liquid crystal materials and a light switching element | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1990-03-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070112037-A1 | Pyrazole Derivatives | CYP11B2, CYP11B1, CYP3A43 | KMT2A 1845/4885HSD17B10 471/4885ALDH1A1 544/4885 |
| US-11518733-B2 | Process for preparation of highly pure Fingolimod hydrochloride | S1PR5, S1PR4, S1PR1 | KMT2A 336/4885HSD17B10 3343/4885ALDH1A1 2287/4885 |
| US-20130217899-A1 | INTERMEDIATE COMPOUNDS AND PROCESS FOR THE PREPARATION OF FINGOLIMOD | S1PR2, S1PR4, S1PR3 | KMT2A 1011/4885HSD17B10 2401/4885ALDH1A1 738/4885 |
| US-20170297999-A1 | METHOD FOR PRODUCING TRIPHENYLBUTENE DERIVATIVE | TERB1, TERT, PAH | KMT2A 682/4885HSD17B10 541/4885ALDH1A1 844/4885 |
| US-20090176744-A1 | Deuterated fingolimod | S1PR1, S1PR3, S1PR4 | KMT2A 780/4885HSD17B10 1875/4885ALDH1A1 2873/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.